Abstract
The anticancer drug mitomycin C (MMC) was conjugated with an affinity-purified horse antibody to human α-fetoprotein (aAFP) with human serum albumin (HSA) as the intermediate drug carrier. The conjugate (aAFP:HSA:MMC molar ratio, 1:1:30) retained full antibody binding activity as determined by a competitive binding radioimmunoassay. In a cytotoxicity test in which the AFP-producing human yolk sac tumor TG-1 cells were preincubated with test materials for 2 h followed by an additional 48-h culture in fresh medium, the conjugate was 20-fold more cytotoxic than free MMC at an equivalent MMC concentration of 100 ng/ml. The in vivo antitumor effect of the conjugate was tested against the human yolk sac tumor JOG-9 growing in athymic nude mice. When the tumor-bearing mice were treated with a total of 6 injections given on 2 consecutive days and then every other day starting 8 days after SC tumor inoculation [2 (equivalent MMC) μg/head per injection], the conjugate retarded tumor growth more effectively than free MMC and normal horse immunoglobulin conjugate.
Keywords: Human Serum Albumin, Athymic Nude Mouse, Tumor Inoculation, Retarded Tumor Growth, Intermediate Drug
References
- 1.Blair AH, Ghose TI. Linkage of cytotoxic agents to immunoglobulins. J Immunol Methods. 1983;59:129. doi: 10.1016/0022-1759(83)90024-8. [DOI] [PubMed] [Google Scholar]
- 2.Einhorn LH, Donohue HJ. Improved chemotherapy in disseminated testicular cancer. J Urol. 1977;117:65. doi: 10.1016/s0022-5347(17)58338-x. [DOI] [PubMed] [Google Scholar]
- 3.Embleton MJ, Rowland GF, Simmonds RG, Jacobs E, Marsden CH, Baldwin RW. Selective cytotoxicity against human tumor cells by a vindesine-monoclonal antibody conjugate. Br J Cancer. 1983;47:43. doi: 10.1038/bjc.1983.5. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Garnett MC, Embleton MJ, Jacobs E, Baldwin RW. Preparation and properties of a drug-carrier-antibody conjugate showing selective antibody-directed cytotoxicity in vitro. Int J Cancer. 1983;31:661. doi: 10.1002/ijc.2910310520. [DOI] [PubMed] [Google Scholar]
- 5.Hirai H, Tsukada Y, Hara A, Hibi N, Nishi S, Wepsic HT, Koji T, Ishii N. Purification of specific antibody to α-fetoprotein and its immunological effect on cancer cells. J Chromatogr. 1981;215:195. doi: 10.1016/s0021-9673(00)81399-0. [DOI] [PubMed] [Google Scholar]
- 6.Hurwitz E, Levy R, Maron R, Wilchek M, Arron R, Sela M. The covalent binding of daunomycin and adriamycin to antibodies, with retention of both drug and antibody activities. Cancer Res. 1975;35:1175. [PubMed] [Google Scholar]
- 7.Kato Y, Tsukada Y, Hara T, Hirai H. Enhanced antitumor activity of mitomycin C conjugate with anti α-fetoprotein antibody by a novel method of conjugation. J Appl Biochem. 1983;5:313. [PubMed] [Google Scholar]
- 8.Kurman RJ, Norris HJ. Endodermal sinus tumor of the ovary, a clinical and pathologic analysis of 71 cases. Cancer. 1976;38:2404. doi: 10.1002/1097-0142(197612)38:6<2404::aid-cncr2820380629>3.0.co;2-3. [DOI] [PubMed] [Google Scholar]
- 9.Mostofi FK, Price EB. Atlas of tumor pathology, 2nd series. Fas. 8, Tumor of the male genital system. Washington, DC: AFIP; 1973. p. 40. [Google Scholar]
- 10.Ohkawa K, Koike K, Amasaki H, Tohtake T, Nakata H, Dohsono H. Heterotransplantation of human embryonal carcinoma into the nude mice, functional and morphologic examination. Asia-Oceania J Obstet Gynecol. 1980;6:73. [Google Scholar]
- 11.Ohkawa K, Hibi N, Tsukada Y. Evaluation of purified antibodies to human AFP-dextran-daunorubicin conjugate in the anti-tumor activity to human AFP-producing yok sac tumor cell lines. Cancer Immunol Immunother. 1986;22:81. doi: 10.1007/BF00199119. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Okabe T, Suzuki A, Ohsawa N, Kosaka K, Terashima T. Immune elimination of host fibroblasts for the cultivation of human tumors transplanted into nude mice. Cancer Res. 1979;39:4189. [PubMed] [Google Scholar]
- 13.Rowland GF, Axton CA, Baldwin RW, Brown JP, Corvalan JR, Embleton MJ, Gore VA, Hellström I, Hellström KE, Jacobs E, Marsden CH, Pimm MV, Simmonds RG, Smith W. Antitumor properties of vindesine-monoclonal antibody conjugates. Cancer Immunol Immunother. 1985;19:1. doi: 10.1007/BF00199304. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Scully RE. Atlas of tumor pathology, 2nd series, Fas. 16, Tumor of the ovary and maldeveloped gonads. Washington, DC: AFIP; 1979. p. 226. [Google Scholar]
- 15.Steel GG, Courtenay VD, Peckham MJ. The response to chemotherapy of a variety of human tumor xenografts. Br J Cancer. 1983;47:1. doi: 10.1038/bjc.1983.1. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Tsukada Y, Bishof WKD, Hibi N, Hirai H, Hurwitz E, Sela M. Effect of a conjugate of daunomycin and antibodies to rat α-fetoprotein on the growth of α-fetoprotein-producing tumor cells. Proc Natl Acad Sci USA. 1982;79:621. doi: 10.1073/pnas.79.2.621. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Tsukada Y, Hurwitz E, Kashi R, Sela M, Hibi N, Hara A, Hirai H. Chemotherapy by intravenous administration of conjugates of daunomycin with monoclonal and conventional anti-rat α-fetoprotein antibodies. Proc Natl Acad Sci USA. 1982;79:7896. doi: 10.1073/pnas.79.24.7896. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Tsukada Y, Kato Y, Umemoto N, Takeda Y, Hara T, Hirai H. An anti-α-fetoprotein antibody-daunorubicin conjugate with a novel poly-L-glutamic acid derivative as intermediate drug carrier. J Natl Cancer Inst. 1984;73:721. [PubMed] [Google Scholar]
- 19.Tsukada Y, Ohkawa K, Hibi N. Suppression of human α-fetoprotein-producing hepatocellular carcinoma growth in nude mice by an anti α-fetoprotein antibody-daunorubicin conjugate with a poly-L-glutamic acid derivate as intermediate drug carrier. Br J Cancer. 1985;52:111. doi: 10.1038/bjc.1985.157. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Umemoto N, Kato Y, Takeda Y, Saito M, Seto M, Takahashi T. Conjugates of mitomycin C with the immunoglobulin M monomer fragment of a monoclonal anti-MM46 immunoglobulin M antibody with or without serum albumin as intermediary. J Appl Biochem. 1984;6:297. [PubMed] [Google Scholar]